tetano
Editor, Senior Moderator
Microb Pathog
. 2021 Apr 28;104908.
doi: 10.1016/j.micpath.2021.104908. Online ahead of print.
Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19
Muthupandian Saravanan[SUP] 1 [/SUP], Ebrahim Mostafavi[SUP] 2 [/SUP], Savariar Vincent[SUP] 3 [/SUP], Hadush Negash[SUP] 4 [/SUP], Rajapriya Andavar[SUP] 5 [/SUP], Venkatesan Perumal[SUP] 6 [/SUP], Namas Chandra[SUP] 6 [/SUP], Selvaraju Narayanasamy[SUP] 7 [/SUP], Kalishwaralal Kalimuthu[SUP] 8 [/SUP], Hamed Barabadi[SUP] 9 [/SUP]
Affiliations
Abstract
In recent decades, the major concern of emerging and re-emerging viral diseases has become an increasingly important area of public health concern, and it is of significance to anticipate future pandemic that would inevitably threaten human lives. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged virus that causes mild to severe pneumonia. Coronavirus disease (COVID-19) became a very much concerned issue worldwide after its super-spread across the globe and emerging viral diseases have not got specific and reliable diagnostic and treatments. As the COVID-19 pandemic brings about a massive life-loss across the globe, there is an unmet need to discover a promising and typically effective diagnosis and treatment to prevent super-spreading and mortality from being decreased or even eliminated. This study was carried out to overview nanotechnology-based diagnostic and treatment approaches for emerging and re-emerging viruses with the current treatment of the disease and shed light on nanotechnology's remarkable potential to provide more effective treatment and prevention to a special focus on recently emerged coronavirus.
Keywords: COVID-19; Coronavirus; Inorganic nanoparticles; Lipid nanoparticles; Nanotherapeutics; Polymeric nanoparticles.
. 2021 Apr 28;104908.
doi: 10.1016/j.micpath.2021.104908. Online ahead of print.
Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19
Muthupandian Saravanan[SUP] 1 [/SUP], Ebrahim Mostafavi[SUP] 2 [/SUP], Savariar Vincent[SUP] 3 [/SUP], Hadush Negash[SUP] 4 [/SUP], Rajapriya Andavar[SUP] 5 [/SUP], Venkatesan Perumal[SUP] 6 [/SUP], Namas Chandra[SUP] 6 [/SUP], Selvaraju Narayanasamy[SUP] 7 [/SUP], Kalishwaralal Kalimuthu[SUP] 8 [/SUP], Hamed Barabadi[SUP] 9 [/SUP]
Affiliations
- PMID: 33932543
- DOI: 10.1016/j.micpath.2021.104908
Abstract
In recent decades, the major concern of emerging and re-emerging viral diseases has become an increasingly important area of public health concern, and it is of significance to anticipate future pandemic that would inevitably threaten human lives. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged virus that causes mild to severe pneumonia. Coronavirus disease (COVID-19) became a very much concerned issue worldwide after its super-spread across the globe and emerging viral diseases have not got specific and reliable diagnostic and treatments. As the COVID-19 pandemic brings about a massive life-loss across the globe, there is an unmet need to discover a promising and typically effective diagnosis and treatment to prevent super-spreading and mortality from being decreased or even eliminated. This study was carried out to overview nanotechnology-based diagnostic and treatment approaches for emerging and re-emerging viruses with the current treatment of the disease and shed light on nanotechnology's remarkable potential to provide more effective treatment and prevention to a special focus on recently emerged coronavirus.
Keywords: COVID-19; Coronavirus; Inorganic nanoparticles; Lipid nanoparticles; Nanotherapeutics; Polymeric nanoparticles.